Figure 1.
Outcomes after CAR T-cell therapy in patients previously exposed to BsAb treatment. (A) OS after CAR T-cell therapy (n = 47). (B) PFS after CAR T-cell therapy (n = 47). (C) Duration of response (DoR) after CAR T-cell therapy (n = 38). CL, confidence limit; NA, not applicable.

Outcomes after CAR T-cell therapy in patients previously exposed to BsAb treatment. (A) OS after CAR T-cell therapy (n = 47). (B) PFS after CAR T-cell therapy (n = 47). (C) Duration of response (DoR) after CAR T-cell therapy (n = 38). CL, confidence limit; NA, not applicable.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal